CytomX Therapeutics, Inc. (CTMX) — Dilution Risk Analysis
Current Snapshot
CytomX Therapeutics, Inc. (CTMX) has a DilutionWatch score of 36/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 36/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: FORM 4 3, XBRL 1.
| Form | Filed | Accession |
|---|---|---|
| Form 4 | 2026-08-03 | 0001610717-26-000351|0001645755|2026-08-03|A|100000 |
| Form 4 | 2026-08-03 | 0001610717-26-000351|0001645755|2026-08-03|A|450000 |
| Form 4 | 2026-07-24 | 0001610717-26-000345|0001719576|2026-07-24|A|118000 |
| xbrl | 2026-03-31 | xbrl-3487-xbrl_warrant |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 18 months | Source |
| Three-year share count growth | 225.28% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 36/10) Source
- Cash Runway
- 18 months Source
- Share Count Growth (3-Year)
- 225.28% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.